The Drugs Controller General of India (DCGI) on Sunday approved the Oxford coronavirus vaccine and Bharat Biotech’s Covaxin, making it India’s first vaccines against the pandemic.
DCGI VG Somani said both the drug firms have submitted data on their trial runs and both have been granted permission for “restricted use”.
The overall efficacy of the Oxford-AstraZeneca Covid-19 vaccine was 70.42%, while Bharat Biotech’s Covaxin was “safe and provides a robust immune response”, VG Somani said.
Hailing the scientific community and frontline Corona warriors, Prime Minister Narendra Modi tweeted, “A decisive turning point to strengthen a spirited fight! DCGI granting approval to vaccines of Serum Institute India
and Bharat Biotech accelerates the road to a healthier and COVID-free nation. Congratulations India. Congratulations to our hardworking scientists and innovators. It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion. We reiterate our gratitude to doctors, medical staff, scientists, police personnel, sanitation workers and all Corona warriors for the outstanding work done, that too in adverse circumstances. We will remain eternally grateful to them for saving many lives”.
“We’ll never approve anything if there is slightest of safety concern. The vaccines are 100% safe. Some side effects like mild fever, pain and allergy are common for every vaccine. It (people may get impotent) is absolute rubbish,” VG Somani said.